Tidemark’s Medtronic MDT Stock Holding History

Tidemark’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17	Closed	-$1.63K	–	701
2025 Q3	$1.63K	Hold	17	–	–	﹤0.01%	612
2025 Q2	$1.48K	Buy	+17	New	+$1.44K	﹤0.01%	621

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tidemark's MDT Position: Q4 2025 in Review

Tidemark sold out of Medtronic (MDT) in Q4 2025, closing a stake of 17 shares — an estimated $1.63K sold.

Tidemark first reported a position in MDT in Q2 2025 and held it in 2 quarters. The position peaked at $1.63K in Q3 2025. 2,315 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Tidemark reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Tidemark sold 17 Medtronic shares in Q4 2025, an estimated $1.63K.
Tidemark first reported a position in Medtronic in Q2 2025 and held it in 2 quarters.
Tidemark's Medtronic position peaked at $1.63K in Q3 2025.
2,315 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Tidemark's 13F filing for Q4 2025, filed 10 Feb 2026.